Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States; Heart and Vascular Institute, Cellular and Molecular Medicine, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Biomedical Engineering, Department of Cell Biology, Johns Hopkins University, Baltimore, MD, United States.
Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Semin Cell Dev Biol. 2021 Oct;118:119-128. doi: 10.1016/j.semcdb.2021.03.011. Epub 2021 Mar 26.
Organoids, or miniaturized organs formed in vitro, hold potential to revolutionize how researchers approach and answer fundamental biological and pathological questions. In the context of cardiac biology, development of a bona fide cardiac organoid enables study of heart development, function, and pathogenesis in a dish, providing insight into the nature of congenital heart disease and offering the opportunity for high-throughput probing of adult heart disease and drug discovery. Recently, multiple groups have reported novel methods for generating in vitro models of the heart; however, there are substantial conceptual and methodological differences. In this review we will evaluate recent cardiac organoid studies through the lens of the core principles of organoid technology: patterned self-organization of multiple cell types resembling the in vivo organ. Based on this, we will classify systems into the following related types of tissues: developmental cardiac organoids, chamber cardiac organoids, microtissues, and engineered heart tissues. Furthermore, we highlight the interventions which allow for organoid formation, such as modulation of highly conserved cardiogenic signaling pathways mediated by developmental morphogens. We expect that consolidation and categorization of existing organoid models will help eliminate confusion in the field and facilitate progress towards creation of an ideal cardiac organoid.
类器官,或在体外形成的微型器官,具有彻底改变研究人员研究和回答基本生物学和病理学问题的方法的潜力。在心脏生物学方面,真正的心脏类器官的开发使人们能够在培养皿中研究心脏的发育、功能和发病机制,深入了解先天性心脏病的本质,并为高通量研究成人心脏病和药物发现提供机会。最近,多个研究小组报告了生成心脏体外模型的新方法;然而,这些方法在概念和方法上存在很大的差异。在这篇综述中,我们将通过类器官技术的核心原则来评估最近的心脏类器官研究:类似于体内器官的多种细胞类型的模式化自组织。基于此,我们将系统分为以下相关类型的组织:发育心脏类器官、心室心脏类器官、微组织和工程心脏组织。此外,我们还强调了允许类器官形成的干预措施,例如通过发育形态发生因子介导的高度保守的心脏发生信号通路的调节。我们期望对现有类器官模型的整合和分类将有助于消除该领域的混乱,并促进创建理想的心脏类器官的进展。